4 analysts have issued 12 month price objectives for Clearside Biomedical's stock. Their forecasts range from $4.00 to $6.00. On average, they expect Clearside Biomedical's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 212.5% from the stock's current price. CLSD Price Target and Analyst Ratings (Clearside Biomedical) Nov 05, 2019 · 4 Wall Street analysts have issued ratings and price targets for Clearside Biomedical in the last 12 months. Their average twelve-month price target is $5.00, suggesting that the stock has a possible upside of 216.46%. The high price target for CLSD is $6.00 and the low price target … CLSD Stock Price | Clearside Biomedical Inc. Stock Quote ... CLSD | Complete Clearside Biomedical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. CLSD | Clearside Biomedical Inc. Analyst Estimates ... CLSD updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services.
CLSD: Clearside Biomedical Inc - Stock Price, Quote ... - CNBC
Clearside Biomedical, Inc. - CLSD - Stock Price Today - Zacks View Clearside Biomedical, Inc. CLSD investment & stock information. Get the latest Clearside Biomedical, Inc. CLSD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. CLSD - Clearside Biomedical, Inc. Summary, Stock Quote and ... Jan 01, 2010 · Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content. Popular Channels Analyst Ratings CLSD Clearside Biomedical — Stock Price and Discussion ... Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. CLSD Stock Price & Charts | Clearside Biomedical
Clearside Biomedical, Inc. (CLSD): What’s Inside the Story ...
Stock quote for Clearside Biomedical, Inc. Common Stock Common Stock (CLSD) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.
Clearside Biomedical started at outperform with $28 stock price target at Wedbush Securities MarketWatch. 07:17 AM ET. Clearside Biomedical started at buy with $13 stock price target at Stifel Nicolaus MarketWatch. Thursday, June 02, 2016. 02:55 PM ET. Clearside Biomedical Goes Public By Cutting Share Price in Half The Wall Street Journal
CLSD Stock Price | Clearside Biomedical Inc. Stock Quote ... CLSD | Complete Clearside Biomedical Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. CLSD | Clearside Biomedical Inc. Analyst Estimates ... CLSD updated stock price target summary. Dow Jones, a News Corp company. News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. CLSD Price Target | Clearside Biomedical Stock Forecast ... See Clearside Biomedical price target based on 3 analysts offering 12 month price targets for Clearside Biomedical in the last 3 months. The average price target is $4.50 with a high forecast of $6.00 and a low forecast of $3.00. The average price target represents a 181.25% increase from the last price of $1.60.
CLSD | Clearside Biomedical Inc. Analyst Estimates ...
Mar 12, 2020 · In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Clearside Biomedical (CLSD – Research Report), with a price target of $6.00.The company’s shares closed last Monday at $2.07. According to TipRanks.com, Moussatos ‘ ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -12.8% and a 30.4% success rate. Clearside Biomedical Inc (CLSD) Stock: What's Next ... Dec 24, 2019 · Clearside Biomedical Inc (CLSD) stock has gained 181.55% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary scoring system, gives CLSD stock a score of 59 out of a possible 100.
CLEARSIDE BIOMEDICAL, INC. : Target Price Consensus and ... CLEARSIDE BIOMEDICAL, INC. analysts consensus, targets, ratings and recommendations | Nasdaq: CLSD | Nasdaq Clearside Biomedical (NASDAQ:CLSD) Rating Reiterated by ...